Telemedicine-based abortion care provider Hey Jane raised $6.1 million. The company sees the new capital as a response to the Supreme Court's "pivotal, unprecedented decision" to overturn Roe v. Wade in June. Hey Jane's success validates industry experts' expectations that Roe's reversal would drive new investment into women's health. “This is going to drive innovation by necessity,” Women’s Health & Wellness partner Delphine O’Rourke told Axios this summer.
In The Press October 19, 2022